Cognitive function in multiple sclerosis and its modulation by cholinergic drugs

Cognitive function in multiple sclerosis and its modulation by cholinergic drugs

<p>In order to assess cognitive function in multiple sclerosis (MS) and the effect of cholinergic modulation, experiments were conducted using functional magnetic resonance imaging (fMRI) to assess the brain activation during cognitive tasks.</p> <p>A study comparing the processin...

Descripció completa

Dades bibliogràfiques
Autors principals:	Cader, S, Cader, Sarah
Altres autors:	Matthews, P
Format:	Thesis
Idioma:	English
Publicat:	2005
Matèries:	Treatment Effect of drugs on Multiple sclerosis Brain Cholinergic mechanisms

Ítems similars

Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis
per: Valentina Gatta, et al.
Publicat: (2020-06-01)

Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis
per: A. N. Boyko, et al.
Publicat: (2019-12-01)

Adherence to Anticholinergic Therapy and Clean Intermittent Self-Catheterization in Patients With Multiple Sclerosis
per: Damien Motavasseli, et al.
Publicat: (2018-06-01)

Exploring the vertebrate cholinergic nervous system /
per: Karczmar, A. G. (Alexander George), 1918-, et al.
Publicat: (2007)

Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
per: Esther Melamed, et al.
Publicat: (2020-01-01)

Brain Stimulation for Cognitive impairment in Multiple Sclerosis (ORP-17)
per: Mehrdad Roozbeh
Publicat: (2023-01-01)

Axonal injury and its mechanisms in multiple sclerosis
per: Xue⁃qiang HU, et al.
Publicat: (2012-04-01)

Comparison Effect of Prescription Drugs on the Occurrence and the Number of Attacks in Patients with Multiple Sclerosis
per: Marjan Jamalian, et al.
Publicat: (2018-01-01)

Role of Cholinergic Signaling in Alzheimer’s Disease
per: Zhi-Ru Chen, et al.
Publicat: (2022-03-01)

Effects of disease-modifying drugs in multiple sclerosis on the gut microbiome
per: Мadina А. Omarova, et al.
Publicat: (2024-01-01)

Multiple Sclerosis and Microbiome
per: Jana Lizrova Preiningerova, et al.
Publicat: (2022-03-01)

Physiotherapy in multiple sclerosis
per: Anna Łuszczyńska, et al.
Publicat: (2015-10-01)

Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region
per: V. B. Laskov, et al.
Publicat: (2017-03-01)

Non-neuronal cholinergic system in the heart influences its homeostasis and an extra-cardiac site, the blood-brain barrier
per: Yoshihiko Kakinuma
Publicat: (2024-03-01)

Multiple sclerosis /
per: 546326 Dobson, Ruth, et al.
Publicat: (2013)

Non-Pharmacological Treatments of Cognitive Impairment in Multiple Sclerosis: A Review
per: Michela Bossa, et al.
Publicat: (2022-08-01)

Adherence to disease-modifying therapies in patients with multiple sclerosis
per: Kołtuniuk A, et al.
Publicat: (2018-08-01)

Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets
per: N. A. Totolyan, et al.
Publicat: (2020-10-01)

Uveitis Related with Multiple Sclerosis
per: Sirel Gür Güngör, et al.
Publicat: (2012-12-01)

Brain atrophy: an in-vivomeasure of disease activity in multiple sclerosis
per: Ernst Wilhelm Radü, et al.
Publicat: (2013-11-01)

Early and severe cognitive impairment in multiple sclerosis
per: Maria Fernanda Mendes, et al.

Optimization of therapy in secondary progressive multiple sclerosis
per: A. N. Boyko, et al.
Publicat: (2024-08-01)

Multiple Sclerosis: Methods of Treatment and Rehabilitation
per: Yuriy Lysenko
Publicat: (2017-06-01)

Improving Visual Working Memory with Cholinergic Deep Brain Stimulation
per: Janki M. Bava, et al.
Publicat: (2023-06-01)

Simulation of Cholinergic and Noradrenergic Modulation of Behavior in Uncertain Environments
per: Michael C Avery, et al.
Publicat: (2012-01-01)

Multiple sclerosis : recovery of function and neurorehabilitation /
per: Kesselring, Jurg, et al.
Publicat: (c201)

Cholinergic Control of Inflammation, Metabolic Dysfunction, and Cognitive Impairment in Obesity-Associated Disorders: Mechanisms and Novel Therapeutic Opportunities
per: Eric H. Chang, et al.
Publicat: (2019-04-01)

General Principles of Treatment of Multiple Sclerosis in Children
per: Shorobura M.
Publicat: (2014-12-01)

Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.
per: Cader, S, et al.
Publicat: (2009)

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey
per: Christian P. Kamm, et al.
Publicat: (2018-10-01)

A review of treatment of relapsing-remitting type of multiple sclerosis (RRMS)
per: Arkadiusz Bydliński, et al.
Publicat: (2024-05-01)

Gut flora in multiple sclerosis: implications for pathogenesis and treatment
per: Weiwei Zhang, et al.
Publicat: (2024-01-01)

Evaluation of association between flu-like syndrome induced by Beta Interferon drug and required drug response in patients with Multiple sclerosis
per: Abdollah Ghaferi, et al.
Publicat: (2019-08-01)

Are highly active and aggressive multiple sclerosis the same entity?
per: Jorge Correale, et al.
Publicat: (2023-03-01)

Cognitive dysfunction in Multiple Sclerosis
per: Joana eGuimarães, et al.
Publicat: (2012-05-01)

A case report of Cholinergic syndrome an unusual complication of Neostigmine administration
per: Z Hussain Khan, et al.
Publicat: (2002-07-01)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
per: Ruth Ann Marrie, et al.
Publicat: (2022-04-01)

Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
per: Weipeng Wei, et al.
Publicat: (2021-07-01)

System biology review of multiple sclerosis and discovery of drug targets (ORP-54)
per: Ali Alizadeh Amiri
Publicat: (2023-01-01)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
per: T. I. Yakushina
Publicat: (2021-02-01)